Found 141 matching trials
CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells PHASE1 The purpose of this study is to collect data on the safety and potential ef...
Show More Location
Roger Williams Medical Center
Learn More & Join Trial
CD4 CAR+ ZFN-modified T Cells in HIV Therapy PHASE1 This research study is being carried out to study a new way to possibly tre...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T N/A Long-term follow-up of study subjects who received AGT103-T product in HIV ...
Show More Status
Enrolling By Invitation
Location
Georgetown University
Learn More & Join Trial
An Evaluation of LY007 Cell Injection for r/r B-NHL PHASE1 An evaluation of LY007 cell injection for recurrent/refractory CD20 was pos...
Show More Learn More & Join Trial
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer PHASE1 This phase I/II trial studies the side effects of gene-modified immune cell...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
NG2 and DLL3 CAR-T Cells Targeting Melanoma PHASE1 The purpose of this study is to assess the feasibility, safety and efficacy...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial
CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases PHASE1 This is an open label fixed dose phase Ib of anti-CEA CAR-T cells hepatic a...
Show More Location
Roger Williams Medical Center
Learn More & Join Trial
A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia PHASE1 This is a single-arm, open-label, phase I dose-escalation clinical study to...
Show More Location
Institute of Hematology & Blood Diseases Hospital, China
Learn More & Join Trial
A Study of GPC3 Redirected Autologous T Cells for Advanced HCC PHASE1 Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Show More Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects PHASE1 This research study is being carried out to study a new way to possibly tre...
Show More Learn More & Join Trial